未登录 分享 收藏
Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study 阿法替尼在具有神经营养因子1（NRG1）融合的实体瘤患者中的应用：Targeted Agent and Profiling Utilization Registry（TAPUR）研究中的病例系列 Rodon, J.; Rothe, M.; Mangat, P. K.; Garrett-Mayer, E.; Cannon, T. L.; Hobbs, E.; Kalemkerian, G. P.; Hinshaw, D. C.; Gregory, A.; Grantham, G. N.; Halabi, S.; Schilsky, R. L. 分享 收藏
分享 收藏
Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Cancer Edwards, Donna M.; Schonewolf, Caitlin A.; Rice, John D.; Schipper, Matthew; Ten Haken, Randall K.; Matuszak, Martha; Balter, James; Jarema, David; Arenberg, Douglas A.; Piert, Morand; Qin, Angel; Kalemkerian, Gregory P.; Schneider, Bryan J.; Ramnath, Nithya; Chapman, Christina H.; Elliott, David A.; Lawrence, Theodore S.; Hearn, Jason; Hayman, James A.; Jolly, Shruti 分享 收藏
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies Sholl, Lynette M.; Awad, Mark; Roy, Upal Basu; Beasley, Mary Beth; Cartun, Richard Walter; Hwang, David M.; Kalemkerian, Gregory; Lopez-Rios, Fernando; Mino-Kenudson, Mari; Paintal, Ajit; Reid, Kearin; Ritterhouse, Lauren; Souter, Lesley A.; Swanson, Paul E.; Ventura, Christina B.; Furtado, Larissa V. 分享 收藏
Precision medicine-based platform to guide the treatment of EML4-ALK fusion lung cancers and other NSCLC Merrill, Nathan M.; Udager, Aaron; Qin, Angel; Lagisetty, Kiran; Bao, Liwei; Cheng, Xu; Madhi, Hamadi; Banerjee, Ananya; Jahromi, Marziyeh Salehi; Goo, Laura; Kathawate, Varun; Vandenburg, Bryce; Aikins, Marisa; Slayton, Mark; Ulintz, Peter; Qin, Zhaoping; Liu, Chia-Jen; Serhan, Habib; Jefferies, John; Ali, Muhammad Sajawal; Navani, Vishal; Monument, Michael; Kratz, Johannes; Smith, Amber; Chang, Andrew; Kalemkerian, Gregory; Nagrath, Sunitha; Hsu, Peggy; Soellner, Matthew B.; Merajver, Sofia D. 分享 收藏
分享 收藏
Pralsetinib in patients with RET fusion-positive non-small cell lung cancer: A plain language summary of the ARROW study Griesinger, Frank; Curigliano, Giuseppe; Subbiah, Vivek; Baik, Christina S.; Tan, Daniel S. W.; Lee, Dae H.; Misch, Daniel; Garralda, Elena; Kim, Dong-Wan; van der Wekken, Anthonie J.; Gainor, Justin F.; Paz-Ares, Luis; Liu, Stephen, V; Kalemkerian, Gregory P.; Bowles, Daniel W.; Mansfield, Aaron S.; Lin, Jessica J.; Smoljanovic, Vlatka; Rahman, Ahmadur; Zalutskaya, Alena; Louie-Gao, Melinda; Boral, Andy L.; Mazieres, Julien 分享 收藏
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive SCLC Kim, Hye Ryun; Awad, Mark M.; Navarro, Alejandro; Gottfried, Maya; Peters, Solange; Csoszi, Tibor; Cheema, Parneet K.; Rodriguez-Abreu, Delvys; Wollner, Mirjana; Yang, James Chih-Hsin; Mazieres, Julien; Orlandi, Francisco J.; Luft, Alexander; Gumus, Mahmut; Kato, Terufumi; Kalemkerian, Gregory P.; Luo, Yiwen; Santorelli, Melissa L.; Pietanza, M. Catherine; Rudin, Charles M. 分享 收藏
分享 收藏
Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial Griesinger, F.; Curigliano, G.; Thomas, M.; Subbiah, V.; Baik, C. S.; Tan, D. S. W.; Lee, D. H.; Misch, D.; Garralda, E.; Kim, D. -W.; van der Wekken, A. J.; Gainor, J. F.; Paz-Ares, L.; Liu, S., V; Kalemkerian, G. P.; Houvras, Y.; Bowles, D. W.; Mansfield, A. S.; Lin, J. J.; Smoljanovic, V.; Rahman, A.; Kong, S.; Zalutskaya, A.; Louie-Gao, M.; Boral, A. L.; Mazieres, J. 分享 收藏
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial 1/2期ARROW试验中RET融合阳性实体瘤患者普拉斯替尼的泛癌疗效 Subbiah, Vivek; Cassier, Philippe A.; Siena, Salvatore; Garralda, Elena; Paz-Ares, Luis; Garrido, Pilar; Nadal, Ernest; Vuky, Jacqueline; Lopes, Gilberto; Kalemkerian, Gregory P.; Bowles, Daniel W.; Seetharam, Mahesh; Chang, Jianhua; Zhang, Hui; Green, Jennifer; Zalutskaya, Alena; Schuler, Martin; Fan, Yun; Curigliano, Giuseppe 分享 收藏
Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer Qin, Angel; Lima, Fatima; Bell, Samantha; Kalemkerian, Gregory P.; Schneider, Bryan J.; Ramnath, Nithya; Lew, Madelyn; Krishnan, Santhoshi; Mohammed, Shariq; Rao, Arvind; Frankel, Timothy L. 分享 收藏
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors 接受免疫检查点抑制剂治疗的转移性非小细胞肺癌患者的骨转移，骨骼相关事件和生存 Qin, Angel; Zhao, Songzhu; Miah, Abdul; Wei, Lai; Patel, Sandipkumar; Johns, Andrew; Grogan, Madison; Bertino, Erin M.; He, Kai; Shields, Peter G.; Kalemkerian, Gregory P.; Gadgeel, Shirish M.; Ramnath, Nithya; Schneider, Bryan J.; Hassan, Khaled A.; Szerlip, Nicholas; Chopra, Zoey; Journey, Sara; Waninger, Jessica; Spakowicz, Daniel; Carbone, David P.; Presley, Carolyn J.; Otterson, Gregory A.; Green, Michael D.; Owen, Dwight H. 分享 收藏
Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC Kim, H. R.; Awad, M. M.; Navarro, A.; Gottfried, M.; Peters, S.; Csoszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Yang, J. C-H.; Mazieres, J.; Orlandi, F. J.; Luft, A.; Gumus, M.; Kato, T.; Kalemkerian, G. P.; Luo, Y.; Santorelli, M. L.; Pietanza, M. C.; Rudin, C. M. 分享 收藏
A Pilot Study of Atezolizumab Plus Hypofractionated Image Guided Radiation Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer Qin, Angel; Rengan, Ramesh; Lee, Sylvia; Santana-Davila, Rafael; Goulart, Bernardo H. L.; Martins, Renato; Baik, Christina; Kalemkerian, Gregory P.; Hassan, Khaled A.; Schneider, Bryan J.; Hayman, James A.; Jolly, Shruti; Hearn, Jason; Lawrence, Theodore S.; Towlerton, Andrea M. H.; Tewari, Muneesh; Thomas, Dafydd; Zhao, Lili; Brown, Noah; Frankel, Timothy L.; Warren, Edus H.; Ramnath, Nithya 分享 收藏
Interplay of Cardiac and Pulmonary Toxicity: An Analysis of Prospective Trials for Locally Advanced Non-Small Cell Lung Cancer Dess, R. T.; Sun, Y.; Matuszak, M. M.; Sun, G.; Schonewolf, C. A.; Kong, F. M.; Gadgeel, S. M.; Kalemkerian, G. P.; Hayman, J. A.; Ten Haken, R. K.; Lawrence, T. S.; Schipper, M.; Jolly, S. 分享 收藏
High Throughput isolation and expansion of circulating tumor cells (CTCs) from Non-small cell lung cancer (NSCLC) patients for personalized treatments Zeinali, Mina; Lee, Maggie; Nadhan, Arthi; Mathur, Anvya; Huang, Wei; Lin, Eric; Harouaka, Ramdane; Wicha, Max S.; Palanisamy, Nallasivam; Hafner, Mathias; Reddy, Rishindra; Kalemkerian, Gregory P.; Schneider, Bryan J.; Hassan, Khaled A.; Ramnath, Nithya; Nagrath, Sunitha 分享 收藏
分享 收藏
Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer Xue, Jianxin; Han, Chengbo; Jackson, Andrew; Hu, Chen; Yao, Huan; Wang, Weili; Hayman, James; Chen, Weijun; Jin, Jianyue; Kalemkerian, Gregory P.; Matuzsak, Martha; Jolly, Struti; Kong, Feng-Ming (Spring) 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
